Sean M. McDonough

Tulane University — United States

Medicine · Health Sciences

23h-index3.5kcitations123works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(49), Immune Cell Function and Interaction(25), T-cell and B-cell Immunology(22), Biblical Studies and Interpretation(22), Immunotherapy and Immune Responses(14)

Publications123 total

Evolving role of the Interleukin-5 antagonist mepolizumab for hypereosinophilic syndrome: pathogenesis and advances in therapy - A narrative review
Advancements in health research.·2025Open Access
Michael F. Bird, Jesus Among the Gods: Early Christology in the Greco-Roman World (Waco, TX: Baylor University Press, 2022), pp. xi + 480. $59.99.
Scottish Journal of Theology·2024
Supplementary Table II from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Figures 1-7 from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Figures 1-7 from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Table I from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Figure Legends from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Table II from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Data from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Data from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Table III from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Table III from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Table I from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Supplementary Figure Legends from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
2023Open Access
Table of contents
Hepatology·2021Open Access
A Single Dose of a Novel Anti-Human CD117-Amanitin Antibody Drug Conjugate (ADC) Engineered for a Short Half-Life Provides Dual Conditioning and Anti-Leukemia Activity and Extends Survival Compared to Standard of Care in Multiple Preclinical Models of Acute Myeloid Leukemia (AML)
Transplantation and Cellular Therapy·2021
A Single Dose of a Novel Anti-Human CD117-Amanitin Antibody Drug Conjugate (ADC) Engineered for a Short Half-Life Provides Dual Conditioning and Anti-Leukemic Activity and Extends Survival Compared to Standard of Care in Multiple Preclinical Models of Acute Myeloid Leukemia (AML)
Blood·2020· 7 cited
OP0307 A NOVEL TARGETED APPROACH TO ACHIEVE IMMUNE SYSTEM RESET: CD45-TARGETED ANTIBODY DRUG CONJUGATES AMELIORATE DISEASE IN PRECLINICAL AUTOIMMUNE DISEASE MODELS AND ENABLE AUTO-HSCT
Annals of the Rheumatic Diseases·2020· 1 citedOpen Access
A Non-Genotoxic Anti-CD117 Antibody Drug Conjugate (ADC) Designed for Patient Conditioning Prior to Stem Cell Transplant and HSC-Based Gene Therapy Has a Broad Therapeutic Window across Species
Biology of Blood and Marrow Transplantation·2020· 1 cited
A Single Dose of a Novel Anti-Human Short Half-Life Engineered CD45-Targeted Antibody-Drug Conjugate (ADC) Is Cytoreductive on Patient-Derived Tumors and Extends Survival Beyond Standards of Care in Multiple Pre-Clinical Models of Hematologic Malignancy
Biology of Blood and Marrow Transplantation·2020Open Access
page 1 of 7Next →

Frequent Co-authors

Jerome Ritz(25), Robert J. Soiffer(19), Corey Cutler(18), Joseph H. Antin(18), Haesook T. Kim(14), Edwin P. Alyea(14), John Koreth(13), Vincent T. Ho(13), Philippe Armand(11), Jennifer Proctor(10), Anthony E. Boitano(10), Karen K. Ballen(9), Ganapathy N. Sarma(9), Sharon L. Hyzy(9), Bradley R. Pearse(8), Rahul Palchaudhuri(8), Thomas R. Spitzer(7), Vassiliki A. Boussiotis(7), Rajiv Panwar(7), Junia Dushime(7)